Spots Global Cancer Trial Database for standard chemotherapy chop + ritiximab
Every month we try and update this database with for standard chemotherapy chop + ritiximab cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Bendamustine Plus Rituximab Versus CHOP Plus Rituximab | NCT00991211 | Non-Hodgkin Lym... Follicular Lymp... Immunocytomas Lymphocytic Lym... Marginal Zone L... | Bendamustine Standard chemot... | 18 Years - | University of Giessen |